155 related articles for article (PubMed ID: 19202318)
1. Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis.
Jin D; Takai S; Sugiyama T; Hayashi T; Fukumoto M; Oku H; Kitaura Y; Ikeda T; Miyazaki M
J Pharmacol Sci; 2009 Feb; 109(2):275-84. PubMed ID: 19202318
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
3. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165
[TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
Arumugam S; Thandavarayan RA; Palaniyandi SS; Giridharan VV; Arozal W; Sari FR; Soetikno V; Harima M; Suzuki K; Kodama M; Watanabe K
Toxicology; 2012 Jan; 291(1-3):139-45. PubMed ID: 22120037
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Jones ES; Black MJ; Widdop RE
J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
[TBL] [Abstract][Full Text] [Related]
6. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P
J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
[TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
Am J Hypertens; 2000 Sep; 13(9):1005-13. PubMed ID: 10981551
[TBL] [Abstract][Full Text] [Related]
8. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
9. Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy.
Masuda T; Muto S; Fujisawa G; Iwazu Y; Kimura M; Kobayashi T; Nonaka-Sarukawa M; Sasaki N; Watanabe Y; Shinohara M; Murakami T; Shimada K; Kobayashi E; Kusano E
Am J Physiol Heart Circ Physiol; 2012 May; 302(9):H1871-83. PubMed ID: 22389386
[TBL] [Abstract][Full Text] [Related]
10. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.
Yamamoto K; Mano T; Yoshida J; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Hori M; Miwa T; Masuyama T
J Hypertens; 2005 Feb; 23(2):393-400. PubMed ID: 15662228
[TBL] [Abstract][Full Text] [Related]
12. Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model.
Fukumoto M; Takai S; Ishizaki E; Sugiyama T; Oku H; Jin D; Sakaguchi M; Sakonjo H; Ikeda T; Miyazaki M
Curr Eye Res; 2008 Oct; 33(10):885-91. PubMed ID: 18853323
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes.
Sugiyama T; Okuno T; Fukuhara M; Oku H; Ikeda T; Obayashi H; Ohta M; Fukui M; Hasegawa G; Nakamura N
Exp Eye Res; 2007 Sep; 85(3):406-12. PubMed ID: 17678894
[TBL] [Abstract][Full Text] [Related]
15. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
Tsutsui H; Matsushima S; Kinugawa S; Ide T; Inoue N; Ohta Y; Yokota T; Hamaguchi S; Sunagawa K
Hypertens Res; 2007 May; 30(5):439-49. PubMed ID: 17587756
[TBL] [Abstract][Full Text] [Related]
17. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
[TBL] [Abstract][Full Text] [Related]
18. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
19. Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.
Singh VP; Baker KM; Kumar R
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1675-84. PubMed ID: 18296558
[TBL] [Abstract][Full Text] [Related]
20. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
Tokuda K; Kai H; Kuwahara F; Yasukawa H; Tahara N; Kudo H; Takemiya K; Koga M; Yamamoto T; Imaizumi T
Hypertension; 2004 Feb; 43(2):499-503. PubMed ID: 14699000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
